|
|
|
市場調查報告書
全球外科用密封劑、接着劑、傷口癒合劑、抗接着劑市場:2008∼2015年
Worldwide Surgical Sealants, Glues, Wound Closure and Anti-Adhesion Markets, 2008-2015
|
本報告已在2012年02月02日停止出版。
更改為出版
Worldwide Surgical Sealants, Glues, Wound Closure and Anti-Adhesion Markets, 2010-2017
出版日期 : 2012年02月
商品編碼: 230643
本報告書為全球外科用密封劑、接着劑、傷口愈合劑、抗接着劑市場之相關分析,包含既存以及新興產品概要、技術開發、2015年為止的市場發展預測、全球各地區動向等,概述如下。
總綱
第1章 臨床需求、處理件數、處置件數
- 組織修復的解剖學與生理學
- 皮膚
- 内部組織與器官
- 各類別創傷分類
- 處理件數
- 現在的外科處置之密封劑、固定劑、止血劑的作用
第2章 科學、技術、開發、臨床以及法規上的課題
- 組織治癒
- 產品開發
- 開發時間線
- 費用效果比
- 法規課題
第3章 產品、技術、預測機會
- 概要
- 開發時間線
- 縫合線、主要成份、其他的機械式被覆裝置
- 膠布
- 止血劑
- 纖維蛋白其他的密封劑產品
- 醫療用接着劑
- 手術後的接着防止
- 傷口癒合劑以及固定劑市場:世界與各地區分析
- 各國、各類別市場
第4章 企業簡介
附錄:企業清單
Abstract
This report details the complete range of sealants & glues technologies used
in traumatic, surgical and other wound closure, from tapes, sutures and
staples to hemostats, fibrin sealants/glues and medical adhesives. The report
details current clinical and technology developments in this huge and rapidly
growing worldwide market, with data on products in development and on the
market; market size and forecast; competitor market shares; competitor
profiles; and market opportunity.
Methodology
This report is a market and technology assessment and forecast of surgical
sealants, glues, hemostasis, other wound closure and anti-adhesion. The report
details the current and emerging products, technologies and markets involved
in wound closure and sealing using sutures and staples, tapes, hemostats,
fibrin and sealant products, medical adhesives and products to prevent
surgical adhesions. The report provides a worldwide historic (from 2008),
current and annual forecast to 2015 of the markets for these technologies,
with particular emphasis on the market impact of new technologies through the
coming decade. The report provides specific forecasts and shares of the
worldwide market by segment for the U.S., Europe (United Kingdom, German,
France, Italy, BeNeLux), Latin America, Japan, Korea and Rest of World.
The report provides background data on the surgical, disease and traumatic
wound patient populations targeted by current technologies and those under
development, and the current clinical practices in the management of these
patients, including the dynamics among the various clinical specialties or
subspecialties vying for patient population and facilitating or limiting the
growth of technologies.
The report establishes the current worldwide market size for major technology
segments as a baseline for and projecting growth in the market over a
five-year forecast. The report also assesses and projects the composition of
the market as technologies gain or lose relative market performance over this
period.
Table of Contents
EXECUTIVE SUMMARY
- Introduction
- Demographic trends
- Consumer-Driven Product Selection
- Mechanisms of Tissue Repair
- Commercial Imperatives
- Industry Consolidation
- Clinical Caseload
- Market Segmentation and Dynamics
- New Surgical Techniques Drive Market Opportunity
- The Uses of Adjunctive Surgical Closure and Securement Products
- Product Development History
- Evolution of Commercial Markets for Sealants and Adhesives
- Overview of Company Strategies
SECTION 1: CLINICAL NEED, CASELOAD, AND PROCEDURE VOLUME
- 1.1 Anatomy and Physiology of Tissue Repair
- 1.2 The Skin
- 1.3 Internal Tissues and Organs
- 1.4 Wound Classification and Types
- 1.4.1 Classification by Morphology and Severity
- 1.4.2 Wound Classification by Cause
- 1.4.3 Surgical Wounds
- 1.5 Caseload
- 1.5.1 Cardiovascular
- 1.5.1.1 Coronary Heart Disease
- 1.5.1.2 Dysfunctional Heart Valves
- 1.5.1.3 Peripheral Vascular Disorders
- 1.5.1.4 Abnormal Aortic Aneurysms
- 1.5.1.5 Drivers of Caseloads for Cardiac Surgery
- 1.5.2 Neurological
- 1.5.2.1 Stroke
- 1.5.2.2 Parkinson' s Disease
- 1.5.2.3 Epilepsy
- 1.5.2.4 Traumatic Injury
- 1.5.2.5 Peripheral Nerve Treatment
- 1.5.2.6 Neurology Drivers
- 1.5.3 Orthopedic
- 1.5.3.1 Hip Replacements
- 1.5.3.2 Knee Replacements
- 1.5.3.3 Cartilage Repair
- 1.5.3.4 Ligament Damage
- 1.5.3.5 Bone Grafting
- 1.5.3.6 Vertebral Disc Repair
- 1.5.3.7 Drivers of Orthopedic Surgery
- 1.5.4 Urological
- 1.5.4.1 Incontinence
- 1.5.4.2 Drivers of Urological Surgery
- 1.5.5 Skin
- 1.5.5.1 Burns
- 1.5.5.2 Pressure Ulcers
- 1.5.5.3 Diabetic Ulcers
- 1.5.5.4 Venous Ulcers
- 1.5.5.5 Plastic Surgery
- 1.6 The Role of Modern Sealant, Securement and Hemostatic
Products in Surgery
- 1.6.1 Fibrin Sealants
- 1.6.2 High-Strength Glues
SECTION 2: SCIENCE, TECHNOLOGY, DEVELOPMENT, CLINICAL AND REGULATORY CHALLENGES
- 2.1 Tissue Healing
- 2.1.1 Hemostasis
- 2.1.2 Proliferation and Maturation
- 2.1.3 Factors That Affect Healing
- 2.2 Product Development
- 2.3 Development Timelines
- 2.3.1 Collagen and Thrombin Combination
- 2.3.2 Polyethylene Glycol Polymer (PEG)
- 2.3.3 Albumin Cross-Linked with Glutaraldehyde
- 2.3.4 Delivery Systems
- 2.4 Cost-Effectiveness
- 2.5 Regulatory Challenges
- 2.5.1 Approval Processes .
- 2.5.2 History of Product Development
- 2.5.3 Regulatory Aspects
SECTION 3: PRODUCTS, TECHNOLOGIES, AND FORECAST OPPORTUNITY
- 3.1 Overview
- 3.2 Development Timeline
- 3.3 Sutures, Staples, and Other Mechanical Closure Devices
- 3.3.1 Sutures, Staples and Mechanical Closure Competitors and Products
- 3.3.2 Sutures, Staples and Mechanical Closure Products in Development
- 3.3.3 Sutures, Staples and Mechanical Closure Market Analysis and
Forecast
- 3.4 Tapes
- 3.4.1 Medical Tape Competitors and Products
- 3.4.2 Medical Tape Market Analysis and Forecast
- 3.5 Hemostats
- 3.5.1 Hemostat Competitors and Products
- 3.5.2 Hemostat Products in Development
- 3.5.3 Hemostat Market Analysis and Forecasts
- 3.6 Fibrin and Other Sealant Products
- 3.6.1 Fibrin and Other Sealant Competitors and Products
- 3.6.2 Fibrin and Other Sealant Products in Development
- 3.6.3 Fibrin and Sealant Market Analysis and Forecasts
- 3.7 High-Strength Medical Adhesives
- 3.7.1 High-Strength Medical Adhesive Competitors and Products
- 3.7.2 High-Strength Medical Adhesive Products in Development
- 3.7.3 High-Strength Medical Adhesive Market Analysis and Forecasts
- 3.8 Post-Surgical Adhesion Prevention
- 3.8.1 Post-Surgical Adhesion Prevention Competitors and Products
- 3.8.2 Post-Surgical Adhesion Prevention Products in Development
- 3.8.3 Post-Surgical Adhesion Prevention Market Analysis and Forecasts
- 3.9 Wound Closure and Securement Markets: Global and Regional Analysis
- 3.9.1 Americas
- 3.9.1.1 United States
- 3.9.1.2 Latin America
- 3.9.2 Japan and Korea
- 3.9.3 Europe
- 3.9.4 Rest of World
- 3.10 Worldwide Markets By Country and Segment
SECTION 4: COMPANY PROFILES
- 3DM, Inc. (3D-Matrix, Ltd.)
- 3M
- Abbott Laboratories
- AccessClosure, Inc.
- Adhezion Biomedical, LLC
- Advanced Medical Solutions plc/Medlogic Global
- Aeris Therapeutics
- Angiotech Pharmaceuticals, Inc.
- Anika Therapeutics, Inc.
- ARC Pharmaceuticals
- Arch Therapeutics, Inc.
- ArthroCare Corporation
- Aso LLC
- Aspen Surgical Products
- Avery Dennison
- B. Braun (Braun Melsungen AG
- Baxter International Inc.
- Berlin Heart GmbH
- Bernsco Surgical Supply (George Tiemann & Co.)
- Biocoral Inc.
- BIOSTER a.s.
- BSN Medical
- C.R. Bard (Bard Medical, Davol)
- Cardiva Medical, Inc.
- Ceremed, Inc.
- Chemence Medical
- Cohera Medical, Inc.
- Collagen Matrix, Inc.
- Coloplast A/S
- Covidien Ltd.
- CryoLife Inc.
- CSIRO PhotoMedical Technologies
- CSL Behring
- CSMG Technologies, Inc. (Live Tissue Connect, Inc.)
- CuraMedical BV
- Derma Sciences, Inc.
- DuPont Applied BioSciences
- Entegrion, Inc.
- FibroGen, Inc.
- Fidia Advanced Biopolymers
- FzioMed Inc.
- Gelita Medical BV
- GEM srl
- Genzyme Biosurgery Inc.
- GluStitch
- Graceduty Company Limited
- Hartmann Group/ Hartmann USA
- Harvest Technologies Corporation
- HemCon Medical Technologies, Inc.
- Hemostasis, LLC
- Human BioSciences, Inc.
- HyperBranch Medical Technology, Inc.
- Incisive Surgical, Inc.
- Innovasa Corporation
- Integra Lifesciences Corporation
- Johnson & Johnson (Ethicon, Inc., Ethicon Endo-Surgery, Inc.)
- Kaketsuken (Chemo-Sero-Therapeutic Research Institute)
- Kensey Nash Corporation
- Kimberly-Clark Health Care
- Kinetic Concepts, Inc.
- King Pharmaceuticals, Inc.
- Kookbo Chemicals Co., Ltd. (KB Chem.)
- Laboratoires Urgo (Urgo Medical)
- LifeBond Ltd.
- Lohmann & Rauscher
- Marine Polymer Technologies
- Medafor, Inc.
- MedTrade Products, Ltd.
- Meyer-Haake GmbH Medical Innovations
- Molnlycke Health Care AB
- Morris Innovative
- Motex Healthcare Corp.
- NeatStitch Ltd.
- Nycomed
- Ocular Therapeutix, Inc.
- Omrix Biopharmaceuticals Inc.
- Pfizer Inc.
- Pharming Group NV
- Piramal Healthcare
- Plasma Technologies, Inc.
- Pluromed, Inc.
- Polyganics
- Polyheal Ltd.
- ProFibrix BV
- Protein Polymer Technologies, Inc.
- Resorba Wundversorgung GmbH & Co. KG
- Scion Cardio-Vascular, Inc.
- Sea Run Holdings
- Smith & Nephew plc
- St. Jude Medical
- Starch Medical, Inc.
- Synovis Life Technologies
- SyntheMed, Inc.
- Teleflex Medical
- ThermoGenesis Corporation
- Thrombotargets Corp.
- Tissuemed Ltd.
- Vascular Solutions, Inc.
- Vectura Group plc
- Vivostat A/S
- Wound Care Technologies, Inc.
- Z-Medica Corporation
- Zimmer
- ZymoGenetics, Inc.
APPENDIX: LIST OF COMPANIES
|

|